Efficacy of Proximal Median Nerve Release
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTampere University Hospital
About this trial
A multi-center randomized controlled clinical trial which determines the efficacy of proximal median nerve release in patients with persistent proximal median nerve compression. The primary outcome is patient reported improvement of symptoms on a 7-point Likert scale at 6 months after the randomization to treatment group.
Eligibility criteria
Qualifiers
Clinically diagnosed PMNC
If the patient has clinically and electrodiagnostically confirmed carpal tunnel syndrome, at least 6 months must have passed since surgical treatment
Age 18 or over
Ability to understand Finnish
Disqualifiers
Nerve root disorder findings in ENMG
Thoracic outlet syndrome, TOS
Other neurological condition that causes upper limb symptoms such as MS, previous nerve injury
Active rheumatoid arthritis or any other active inflammatory joint disease that affects hand function
Trial design
Treatments tested in this trial
- Proximal median nerve release
- Physiotherapy
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Tampere University Hospital
Lead sponsor
Seinajoki Central Hospital
Collaborator
Source ClinicalTrials.gov